PharmaCyte Biotech

(NASDAQ) PMCB

Current Price$0.69

Market Cap$7.51M

Since IPO (2003)-100%

5 Year-96%

1 Year-37%

1 Month-9%

PharmaCyte Biotech Financials at a Glance

Market Cap

$7.51M

Revenue (TTM)

$0.00

Net Income (TTM)

-$3.28M

EPS (TTM)

-$1.04

P/E Ratio

-0.67

Dividend

$0.00

Beta (Volatility)

0.55 (Low)

Dividend

$0.00

Beta (Volatility)

0.55 (Low)

Price

$0.69

Volume

196,592

Open

$0.73

Price

$0.69

Volume

196,592

Open

$0.73

Previous Close

$0.70

Daily Range

$0.67 - $0.74

52-Week Range

$0.63 - $1.51

Estimated Earnings Date

Jul 1, 2026

Dividend

$0.00

Beta (Volatility)

0.55 (Low)

Price

$0.69

Volume

196,592

Open

$0.73

Previous Close

$0.70

Daily Range

$0.67 - $0.74

52-Week Range

$0.63 - $1.51

Estimated Earnings Date

Jul 1, 2026

PMCB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PharmaCyte Biotech

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Joshua Nathaniel Silverman

Website

pharmacyte.com

Headquarters

Las Vegas, NV 89169, US

PMCB Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-8%

Return on Capital

-10%

Return on Assets

-6%

Earnings Yield

-1.49%

Dividend Yield

0.00%

Payout Ratio

-4.96%

Stock Overview

Market Cap

$7.51M

Shares Outstanding

10.74M

Volume

196.59K

Avg. Volume

198.86K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$4.38M

EBITDA

$30.66M

Operating Cash Flow

-$2.98M

Capital Expenditure

-$4.00

Free Cash Flow

-$2.98M

Cash & ST Invst.

$15.54M

Total Debt

$0.00

PharmaCyte Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$7.51M

N/A

Market Cap/Employee

$3.76M

N/A

Employees

N/A

Net Income

$746.86K

+124.5%

EBITDA

-$2.12M

-120.6%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Net Cash

$20.54M

+22.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-5.87%

N/A

Return on Invested Capital

-9.94%

N/A

Free Cash Flow

-$786.85K

-54.3%

Operating Cash Flow

-$786.85K

-54.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BCLIBrainstorm Cell Therapeutics Inc.

BCLIBrainstorm Cell Therapeutics Inc.$0.75-2.60%

TCRTAlaunos Therapeutics, Inc.

TCRTAlaunos Therapeutics, Inc.$2.28-6.56%

RADXRadiopharm Theranostics Limited

RADXRadiopharm Theranostics Limited$4.32-6.70%

KTTAPasithea Therapeutics Corp.

KTTAPasithea Therapeutics Corp.$0.59-5.63%

VIVSVivoSim Labs, Inc.

VIVSVivoSim Labs, Inc.$1.20-10.45%

QNRXQuoin Pharmaceuticals, Ltd.

QNRXQuoin Pharmaceuticals, Ltd.$4.49+4.66%

CYCNCyclerion Therapeutics, Inc.

CYCNCyclerion Therapeutics, Inc.$2.98-2.45%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.38-0.13%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.05-0.14%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.19+0.14%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$34.14-0.05%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$705.06-0.05%

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF$11.87-0.11%

SOFISoFi Technologies

SOFISoFi Technologies$16.03-0.07%

Questions About PMCB

What is the current price of PharmaCyte Biotech?

PharmaCyte Biotech is trading at $0.70 per share.

What is the 52-week range for PharmaCyte Biotech?

Over the past 52 weeks, PharmaCyte Biotech has traded between $0.63 and $1.51.

How much debt does PharmaCyte Biotech have?

As of the most recent reporting period, PharmaCyte Biotech reported total debt of $0.00.

How much cash does PharmaCyte Biotech have on hand?

PharmaCyte Biotech reported $20.17M in cash and cash equivalents in its most recent financial results.

What is PharmaCyte Biotech’s dividend yield?

PharmaCyte Biotech does not currently have a dividend yield.

PharmaCyte Biotech

PharmaCyte Biotech Financials at a Glance

PMCB News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About PharmaCyte Biotech

PMCB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

PharmaCyte Biotech Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PMCB

What is the current price of PharmaCyte Biotech?

What is the 52-week range for PharmaCyte Biotech?

How much debt does PharmaCyte Biotech have?

How much cash does PharmaCyte Biotech have on hand?

What is PharmaCyte Biotech’s dividend yield?

Premium Investing Services